OLYNT 0.1% nasal spray Composition:
1 ml solution contains 1.0 mg xylometazoline hydrochloride Preservative: 0.2 mg benzalkonium chloride
Excipients: edetate disodium, sodium chloride, sodium dihydrogen phosphate dihydrate, sodium phosphate dihydrate, sorbitol, distilled water
OLYNT nasal spray Indications:
· To reduce the swelling of the nasal mucosa in acute rhinitis, attacks of profuse nasal secretions (vasomotor rhinitis), allergic rhinitis (allergic rhinitis).
· To facilitate the outflow of secretions in cases of paranasal sinusitis and catarrh of the tubal part of the middle ear in combination with colds.
Olynth 0.1% is intended for adults and school-age children (over 6 years).
OLYNT nasal spray Contraindications:
This medicine should not be used in the following cases:
- hypersensitivity to one of the components of Olint 0.1%
- dry inflammation of the nasal mucosa (dry rhinitis) children under 6 years of age.
Due to the use of non-alconium chloride as a preservative, Olint 0.1% should not be used in case of known hypersensitivity to this substance.
This medicine should be used with careful consideration of the benefits and risks in patients:
- who have been treated with monoamine oxidase inhibitors (MAO inhibitors) or other medicines with potentially hypertensive effects
- in case of increased intraocular pressure, in particular narrow-angle glaucoma
with severe cardiovascular disease (eg ischemic heart disease, hypertension)
- with metabolic diseases (eg hyperthyroidism, diabetes).
Use in pregnant and lactating women
Xylometazoline should not be used during breast-feeding as there are no indicative studies on the effects of the drug on the fetus. The drug should not be used during lactation because it is not known whether the active substance is excreted in breast milk.
When driving, operating machinery or working in unsafe places
With long-term use and in high doses of Olint 0.1%, effects on the cardiovascular system cannot be ruled out. This may impair your ability to drive and use machines.
Side effects
Respiratory system
Olint 0.1% may cause transient, mild symptoms of irritation (burning or dryness of the nasal mucosa) in the nose in sensitive patients.
In isolated cases, after depletion of the effect of the drug, an increase in mucosal edema may be observed (reactive hyperemia).
With prolonged or frequent use, or in higher doses of Olint 0.1%, a burning sensation or dryness of the mucosa may occur. and reactive congestion caused by drug overdose (drug-induced rhinitis). This effect can be observed even after 5-7 days of treatment, after prolonged application and can cause temporary damage to the mucosa with the formation of crusts (dry rhinitis).
Nervous system
Extremely rarely, headache, insomnia or fatigue may occur.
Cardiovascular system
Cardiac and circulatory effects, such as palpitations, rapid heartbeat and high blood pressure, are sometimes seen.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.
OLYNT nasal spray Dosage and method of administration:
The following instructions apply to the use of Olint 0.1%, unless otherwise prescribed by your doctor. Please read the application instructions to ensure the correct action of Olint 0.1%.
Do not exceed the recommended doses and duration of treatment.
Unless otherwise prescribed for adults and school-age children, 1 injection of Olint 0.1% Dosing Spray in each nostril is administered, if necessary, up to 3 times a day. The dosage depends on the individual sensitivity of the patient and the clinical effect.
Do not use xylometazoline dosing spray for more than 5 to 7 days unless otherwise prescribed by a doctor.
Re-use should only be performed after an interval of several days.
Consult your doctor about the duration of use in children.
Use in chronic rhinitis should be performed only under medical supervision.